Balderton Capital launches $1.3bn funds to boost European tech startups

WT default author logo
Women's Tabloid News Desk

Balderton Capital, one of Europe’s foremost venture capital firms, has revealed the launch of two significant new funds totaling $1.3 billion, a move set to bolster Europe’s entrepreneurial landscape. These funds, which include a $615 million Early Stage Fund IX and a $685 million Growth Fund II, are designed to support the continent’s most promising startups from their earliest stages right through to initial public offerings (IPOs).

The fresh influx of capital has drawn the attention of a diverse group of investors, among them a major U.S. state pension fund and British Patient Capital, underscoring the confidence global institutions have in Balderton’s approach.

Balderton’s portfolio is a testament to its success, featuring companies such as Revolut, Dream Games, and GoCardless. The firm is well-known not just for its financial backing but also for the extensive support it provides to founders. This includes a dedicated platform team, experienced Executives in Residence, and a robust community network.

Moreover, Balderton is recognized for its pioneering founder wellbeing initiatives, reflecting its commitment to supporting entrepreneurs beyond just business growth. The firm’s track record includes several high-profile exits, including those of cybersecurity giant Darktrace and fashion marketplace Depop, further solidifying its reputation as a key player in the venture capital space.

Share:

Related Insights

Jen Browning appointed as Chief Executive Officer of Transport for All

Cross-Border Impact Ventures secures $58 million first close for second health technology fund

New Look names Lynda Petherick as Chief Executive Officer following financial turnaround

DITTO secures $6 million seed funding to scale clinical menstrual health range

REC names Louise Hanson as new Chief Executive to lead UK recruitment sector

Invest in Women Taskforce hits major milestone with over £100 million deployed

Applications open for W Accelerate women’s health programme with Merck and M Ventures

Chiron secures £900,000 seed funding to expand AI healthcare platform